565 PHASE 3 EFFICACY AND SAFETY OF ONCE-MONTHLY OXYBUTYNIN VAGINAL RING DELIVERING 4 MG/DAY OR 6 MG/DAY VS PLACEBO RING IN WOMEN WITH URGE INCONTINENCE, FREQUENCY, AND URGENCY SYMPTOMS OF OVERACTIVE BLADDER
Keyword(s):
Phase 3
◽